Curaleaf Holdings (CURLF) Current Leases (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Current Leases of $11.7 million for Q4 2025, down 32.59% year-on-year from $17.3 million in Q4 2024, and down 32.59% on a QoQ basis from $17.3 million in Q4 2024.
Curaleaf Holdings (CURLF) Current Leases (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Current Leases for 7 consecutive years, with $11.7 million the latest figure, recorded in Q4 2025.
- Quarterly Current Leases fell 32.59% year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.7 million (down 32.59% YoY) and the FY2025 annual result came in at $11.7 million, down 32.59% from the prior year.
- Current Leases eased to $11.7 million in Q4 2025 per CURLF's latest filing, from $17.3 million in the prior quarter.
- Over the last five years, Current Leases for CURLF reached as high as $22.1 billion in Q1 2022 and fell as low as $4.6 million in Q4 2021.
- A 5-year average of $1.7 billion and a median of $17.0 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases tumbled 70.94% — and 2022, when it soared 134675.97%.
- Year by year, Current Leases stood at $4.6 million in 2021, then surged by 272.42% to $17.0 million in 2022, then dropped by 5.93% to $16.0 million in 2023, then gained by 8.38% to $17.3 million in 2024, then sank by 32.59% to $11.7 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $11.7 million, $17.3 million, and $10.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.68 Mn |
| Dec 31, 2024 | 17.33 Mn |
| Sep 30, 2024 | 10.71 Mn |
| Jun 30, 2024 | 10.16 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 24.15 Mn |
| Jun 30, 2022 | 23.27 Mn |
| Mar 31, 2022 | 22.08 Bn |
| Dec 31, 2021 | 4.57 Mn |
| Sep 30, 2021 | 17.94 Mn |
| Jun 30, 2021 | 18.31 Mn |
| Mar 31, 2021 | 16.38 Mn |
| Dec 31, 2020 | 15.71 Mn |
| Sep 30, 2020 | 39.79 Mn |
| Dec 31, 2019 | 11.84 Mn |